Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Cancer. 2012 Apr 19;118(22):5663–5670. doi: 10.1002/cncr.27563

Table 2.

Grade 3 and 4 toxicities observed during RET5 window therapy

Group
G-CSF
(n=17)
No G-CSF
(n=10)
Grade 3 Grade 4 Grade 3 Grade 4
n n n n
Hematologic toxicities
   Hemoglobin 11 8
   Leukocytes (total WBC) 3 1 3
   Neutrophils/granulocytes (ANC/AGC) 17 10
   Platelets 8 3 1 4
Non-hematologic toxicities
   Allergic reaction 1
   Anorexia 2 1
   Colitis, infectious (e.g., Clostridium difficile) 1* 1
   Dehydration 2
   Diarrhea 2 1 2
   Febrile neutropenia 2 3
   Fever without neutropenia 1 1
   Glucose, serum-low (hypoglycemia) 1
   Infection with Grade 3 or 4 neutropenia 2
   Mucositis/stomatitis (clinical exam), Oral cavity 2
   Pulmonary 1
   Rash/desquamation 2 1
   Vomiting 1 1

Abbreviations: AGC, absolute granulocyte count; WBC, white blood cell count

*

This patient had clinical findings consistent with colitis and adenovirus was identified in the stool.

This patient had Clostridium difficile colitis and required intravenous antibiotics.

One patient had balanitis and the other had respiratory syncytial virus infection.